Cancer as a Global Health Priority

Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19

Résumé en anglais

Cancer imposes a profound burden on low- and middle-income countries (LMICs) where 65% of approximately 10 million global cancer deaths in 2020 occurred. Moreover, global cancer morbidity and mortality are increasing due to demographic and epidemiological transitions, with 16 million global cancer deaths projected in 2040, an estimated 69% of which will occur in LMICs. The lowest-income countries will experience the greatest proportional increases, with a projected near doubling of cancer deaths.COVID-19 is exacerbating global cancer morbidity and mortality because hospital and clinic shutdowns have forced many delayed or missed prevention and screening visits, evaluations for cancer-related symptoms, and cancer treatments in high-income countries and LMICs. The global response to COVID-19 has demonstrated marked inequities, with escalating cases and limited access to vaccines and other control measures in LMICs. Accelerating efforts to address COVID-19 in LMICs are encouraging, and this recommitment to health equity should extend to all populations and diseases.